May Han
Private Equity Investor bei Cure Ventures Management LP
Aktive Positionen von May Han
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.09.2021 | - |
Karriereverlauf von May Han
Ehemalige bekannte Positionen von May Han
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOVARTIS AG | Direktor/Vorstandsmitglied | 01.10.2013 | 30.09.2021 |
| AVEO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.10.2003 | 30.06.2012 |
Ausbildung von May Han
| Peking University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Schweiz | 2 |
| China | 2 |
Operativ
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
